Novartis Motion Is Wolf In Sheep's Clothing: Plaintiffs

Law360, New York (September 4, 2007, 12:00 AM EDT) -- Plaintiffs in the consolidated litigation over bone drugs Aredia and Zometa have slammed Novartis Pharmaceutical Corp.'s bid to break up their proposed classes as a veiled move for dismissal.

The suits, now consolidated in a Nashville district court, all accuse Novartis of strict liability and negligence in the production and distribution of the two drugs, which have been linked to osteonecrosis of the jaw, a condition involving painful deterioration of the jawbone.

In Wood v. Novartis, which concerned patients who had taken Aredia, and in Becker...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.